期刊文献+

1例两性霉素B治疗隐球菌性脑膜炎致低钾血症病例分析 被引量:1

Hypokalemia Induced by Amphotericin B in the Treatment of Cryptococcal Meningitis:A Case Report
下载PDF
导出
摘要 目的 探讨两性霉素B治疗隐球菌性脑膜炎致低钾血症的相关因素和防治对策。方法 临床药师参与1例两性霉素B治疗隐球菌性脑膜炎致低钾血症患者治疗方案的调整,结合相关文献和指南分析出现低钾血症的原因,计算补钾治疗剂量,并调整治疗方案。结果 临床药师建议口服枸橼酸钾3.0 g(每天3次)后加用10%氯化钾注射液静脉补钾治疗,患者血清钾含量稳定,继续口服补钾治疗,抗真菌感染治疗有效,血清钾紊乱得到及时纠正,恢复正常。结论 临床药师从药学角度为低钾血症患者提供补钾方案,可辅助医师诊疗,提高疗效,减少药品不良反应。 Objective To investigate the related factors,prevention and treatment strategies of hypokalemia induced by amphotericin B in the treatment of cryptococcal meningitis.Methods The clinical pharmacists participated in the adjustment of the treatment scheme of a patient with hypokalemia induced by amphotericin B in the treatment of cryptococcal meningitis.They analyzed the causes of hypokalemia based on the relevant literature and guidelines,calculated the dosage of potassium supplementation,and adjusted the treatment scheme.Results The clinical pharmacists suggested adding 10%Potassium Chloride Injection intravenously for potassium supplementation after oral administration of 3.0 g potassium citrate(three times a day),then the patient'serum potassium content was stable,and he took orally potassium supplementation continuously.The antifungal infection treatment was effective,the disorder of serum potassium content was corrected in time,and the above index returned to the normal level.Conclusion Clinical pharmacists provide the potassium supplementation scheme for patients with hypokalemia from the perspective of pharmacy,which can assist physicians in diagnosis and treatment,improve the efficacy and reduce the incidence of adverse drug reactions.
作者 马明明 王娜 朱珊珊 丁晓晴 费群 何心 MA Mingming;WANG Na;ZHU Shanshan;DING Xiaoqing;FEI Qun;HE Xin(Heilongjiang Provincial Hospital,Harbin,Heilongjiang,China 150036)
机构地区 黑龙江省医院
出处 《中国药业》 CAS 2023年第7期111-113,共3页 China Pharmaceuticals
基金 黑龙江省卫生健康委员会科研课题[2019-131]。
关键词 两性霉素B 隐球菌性脑膜炎 低钾血症 药学监护 amphotericin B cryptococcal meningitis hypokalemia pharmaceutical care
  • 相关文献

参考文献4

二级参考文献40

  • 1陈瑞玲,赵志刚.两性霉素B及其新型制剂的合理应用[J].中国药学杂志,2005,40(20):1595-1596. 被引量:12
  • 2韦继政,李素珍,吕小亮.静脉联合鞘内应用两性霉素B治疗隐球菌性脑膜炎23例的不良反应及疗效观察[J].蛇志,2006,18(2):107-110. 被引量:4
  • 3朱利平,翁心华,杨飞飞,章强强,李谦,金嘉琳,蒋为民,施光峰,章婉琴,张永信.伊曲康唑治疗中枢神经系统真菌感染的临床开放研究[J].中国新药与临床杂志,2006,25(11):822-826. 被引量:12
  • 4Fujita Y, Kasahara K, Konishi M, et al. Amphotericin B-induced nephro- genic diabetes insipidus in a case of cryptoeoecemia [ J ]. Intern Med,2005,44(5):458.
  • 5Gerbaud E, Tamion F, Girauh C,et al. Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome) [J] .J Antimicrob Chemother, 2003,51 (2) :473.
  • 6Hopp L,Bernardi J, Reeves G. Amphotericin B-induced partial nephro- genic diabetes insipidus[J]. Pediatr Nephrol, 2001,16:594.
  • 7Deray G . Amphotericin-B nephrotoxicity[ J]. Chemother , 2002,49( 1 ) : 37.
  • 8Karimzadeh I, Farsaei S, Khalili H, et al. Are salt loading and prolonging infusion period effective in prevention of amphoteriein B-induced nephro- toxicity [J]. Expert Opin Drug Saf, 2012,11 ( 6 ) : 969.
  • 9Bekersky I, Fielding RM, Dressier DE,et al. Pharmaeokinetics, excre- tion, and mass balance of liposomal amphoteriein B (AmBisome) and amphotericin B deoxycholate in humans [J]. Antimicrob Agents Chemoth- er,2002,46(3) :828.
  • 10Mistro S, Maciel IM, Menezes RG, et al. Does lipid emulsion reduce am- photericin B nephrotoxicity? A systematic review and meta-analysis[J]. Clin Infect Dis, 2012,54(12) : 1774.

共引文献182

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部